Inflammation in the Disease: Mechanism and Therapies 2014View this Special Issue
Review Article | Open Access
Ionotropic and Metabotropic Proton-Sensing Receptors Involved in Airway Inflammation in Allergic Asthma
An acidic microenvironment has been shown to evoke a variety of airway responses, including cough, bronchoconstriction, airway hyperresponsiveness (AHR), infiltration of inflammatory cells in the lung, and stimulation of mucus hyperproduction. Except for the participation of transient receptor potential vanilloid-1 (TRPV1) and acid-sensing ion channels (ASICs) in severe acidic pH (of less than 6.0)-induced cough and bronchoconstriction through sensory neurons, the molecular mechanisms underlying extracellular acidic pH-induced actions in the airways have not been fully understood. Recent studies have revealed that ovarian cancer G protein-coupled receptor 1 (OGR1)-family G protein-coupled receptors, which sense pH of more than 6.0, are expressed in structural cells, such as airway smooth muscle cells and epithelial cells, and in inflammatory and immune cells, such as eosinophils and dendritic cells. They function in a variety of airway responses related to the pathophysiology of inflammatory diseases, including allergic asthma. In the present review, we discuss the roles of ionotropic TRPV1 and ASICs and metabotropic OGR1-family G protein-coupled receptors in the airway inflammation and AHR in asthma and respiratory diseases.
Airway acidification has been shown to be attained by either the exogenous way, that is, the microaspiration of acid contents into the airway during gastroesophageal reflux and inhalation of low pH pollutant aerosol, or the endogenous way, that is, ischemia and inflammation of the airways in inflammatory diseases, such as asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD) [1–3]. In ischemic and inflammatory situations, the stimulation of anaerobic glycolysis causes lactate production. In patients with asthma, it has been reported that airway pH reaches 5.2 to 7.1, depending on the severity: pH is normalized with corticosteroid therapy . Although alteration of airway pH may serve an innate host defense capacity, that is, inhibiting the survival of bacteria in an acidic environment, it is also implicated in the pathophysiology of obstructive airway diseases. Thus, exposure to acids evokes a cough, bronchoconstriction, airway hyperreactivity (AHR), and microvascular leakage and stimulates mucus production . However, molecular mechanisms underlying the extracellular acidic pH-induced actions in the airways have not been fully understood. In the present review, we discuss the proton-sensing mechanisms, focusing on proton-sensing ionotropic receptors, such as transient receptor potential vanilloid-1 (TRPV1) and acid-sensing ion channels (ASICs), and metabotropic ovarian cancer G protein-coupled receptor 1 (OGR1)-family G protein-coupled receptors (GPCRs), in the airway inflammation and AHR in asthma and respiratory diseases.
2. General Information Regarding Proton-Sensing Channels and OGR1-Family GPCRs
The mammalian transient receptor potential (TRP) superfamily of nonselective cation channels encompasses 28 isotypes and is divided into six subfamilies, that is, TRPC, TRPV, TRPM, TRPA, TRPP, and TRPML. These channels are expressed in neurons and a wide range of cell types in many biological systems [4–6]. TRP channels have six putative transmembrane domains and a pore-forming loop between the fifth and sixth segments. They are thought to be composed of homo- or heterotetramers . Among them, capsaicin-sensitive TRPV1 is activated by a diverse range of chemical and noxious stimuli, including protons [5–7]. TRPV1 senses relatively strong acidic pH of 4 to 5 through glutamic acid in the extracellular domain of the channel  (Figure 1). TRP channels other than TRPV1, including TRPA1, TRPV4, and TRPM8, are expressed in the respiratory system and involved in the regulation of airway functions [8–10]; however, whether protons practically trigger their channel activation remains unknown.
Another important family of proton-sensing channel is ASIC. ASICs are proposed to assemble as tetramers with homomeric or heteromeric subunits; each subunit consists of two transmembrane domains  (Figure 1). Six ASIC subunit proteins, encoded by four genes, have been identified: ASIC1a, ASIC1b, ASIC2a, ASIC2b, ASIC3, and ASIC4. ASICs are voltage-independent channels that mainly conduct Na+ . Recent studies have demonstrated that ASICs activated by acidic pH play an important role in a wide range of physiological and pathophysiological processes such as nociception, mechanosensation, synaptic plasticity, and acidosis-mediated neuronal injury . Histidine, glutamic acid, and aspartic acid may determine a broad range of optical pH of 4 to 7 for activation, depending on the subtypes [4, 13, 14]. Some forms of ASIC mRNAs have been detected in pulmonary sensory neurons .
In addition to TRPV1 and ASICs, there is increasing evidence that further acid-sensitive ion channels are involved in monitoring acidosis. These include TRP family ion channels other than TRPV1, including TRPV4, TRPC4, TRPC5, and TRPP2 (PKD2L1); two-pore domain K+ () channels; ionotropic purinoceptors (P2X); inward rectifier K+ channels; voltage-activated K+ channels; L-type Ca2+ channels; hyperpolarization-activated cyclic nucleotide gated channels; gap junction channels; and Cl− channels . Although most of these channels seem to be expressed and play important roles in the respiratory system, their extracellular proton-sensitivity has not, to our knowledge, been demonstrated for specific airway responses [10, 15–17].
Recent studies suggest that OGR1-family GPCRs, including OGR1 (GPR68), GPR4, and T cell-death associated gene 8 (TDAG8 or GPR65), also sense extracellular protons and, thereby, stimulates a variety of cellular activities through several types of G proteins [18–21] (Figure 1). This receptor family is expressed not only in neurons but also in nonneuronal cells. OGR1-family GPCRs were previously described as GPCRs for lysolipids, such as sphingosylphosphorylcholine [19–21]. Ludwig et al. , however, first discovered that OGR1 and GPR4 sense extracellular protons and are coupled to Gq and Gs, leading to activation of the phospholipase C/Ca2+ signaling pathway and the adenylyl cyclase/cAMP signaling pathway, respectively . Later it was found that TDAG8 similarly senses extracellular protons, leading to the activation of the cAMP signaling pathway [22, 23]. OGR1-family GPCRs sense weak acidic to weak alkaline pH of 6 to 8 through histidine residues [18, 19, 24, 25]. G2A is also classified in this receptor family and is expressed by a broad range of immunoregulatory cell types, including macrophages, dendritic cells, neutrophils, mast cells, and T and B cells, and it is suggested to play an important role in innate and adaptive immunity . However, the proton sensitivity of the receptor is very small and its role as a proton sensor has been questioned . In the present review, therefore, we do not focus further on G2A. OGR1-family GPCRs are expressed in many cell types localized in the airways, and the cases in which their roles are demonstrated are summarized in Figure 2.
3. Role of Proton-Sensing Channels and GPCRs in the Airways
3.1. Bronchoconstriction and AHR
3.1.1. Sensory Neurons
The proton-sensing TRPV1 channel and/or ASICs in sensory nerves have first been proposed to be involved in acidic pH-induced airway responses [2, 28, 29]. It has been established that TRPV1 on capsaicin-sensitive primary sensory neurons plays an important role in nociception and transmission of pain as a sensor of noxious stimuli [2, 4, 30]. The activation of TRPV1 on the sensory neurons by irritant compounds, including capsaicin and citric acid, generates reflex responses that, in turn, stimulate the release of tachykinins from the terminals of the sensory nerves, causing cough and bronchoconstriction [2, 5, 29]. The possibility that the afferent signals and neuropeptide release are coupled at the same nerve endings has also been proposed . The neurogenic role of TRPV1 was based mainly upon experiments with selective agonists and antagonists. For example, capsazepine, a TRPV1-selective antagonist, and SR48968, a selective NK2 receptor antagonist, blocked citric acid inhalation-induced bronchoconstriction in guinea pig airways in vivo . The role of TRPV1 in AHR has recently been demonstrated by the finding that oral administration of TRPV1-specific antagonists significantly attenuated AHR in the asthma model of OVA-sensitized guinea pigs . In addition to TRPV1, involvement of ASICs in acidic pH-induced AHR was suggested by using selective ASIC inhibitors in the guinea pig tracheal rings ex vivo . These results suggest that bronchoconstriction and AHR under acidic environments are indirectly mediated by sensory neurons through proton-sensing channels, such as TRPV1 and ASICs [6, 30]. In fact, no report has shown that TRPV1 and ASICs are expressed and are directly functioning in ASM cells, although vascular smooth muscle cells seem to express TRPV1  and ASICs .
3.1.2. Airway Smooth Muscle (ASM) Cells
The previous studies, however, did not rule out the direct actions of acidic pH on ASM cells. Ichimonji et al.  showed that extracellular acidification stimulates mRNA expression and protein production of IL-6, a proinflammatory cytokine, in association with the phosphorylation of extracellular signal-regulated kinase (ERK) and p38MAPK, in human ASM cells. They also showed that extracellular acidification induced an increase in intracellular Ca2+ concentration , which was accompanied by ASM cell contraction . Acidification also induced expression of connective tissue growth factor (CTGF), a critical factor involved in the formation of extracellular matrix proteins and, hence, airway remodeling. TGF-β-induced CTGF expression was also enhanced by acidic pH . In ASM cells, OGR1 is expressed at by far the highest levels among proton-sensing GPCRs . The knockdown of OGR1 and Gq with their specific small interfering RNAs and an inhibition of Gq with YM-254890 attenuated the acidification-induced actions [35, 37]. These results suggest that extracellular acidification stimulates Ca2+ mobilization, inflammatory cytokine IL-6 and CTGF production, and contraction through OGR1/Gq in human ASM cells (Figure 2).
The role of OGR1 in AHR is supported by recent findings with RGS2-  and RGS5-deficient mice . RGS2 and RGS5 are GTPase-activating proteins that inactivate Gq stimulated by Gq-coupled receptors, including OGR1. Xie et al.  showed that RGS2 deficiency caused spontaneous AHR in response to methacholine without any prior antigen sensitization/challenge. They also showed that the loss of RGS2 augmented Ca2+ mobilization and the contraction of ASM cells, increased ASM mass, and stimulated ASM cell growth via ERK and phosphatidylinositol 3-kinase (PI3K) pathways. These results are highly consistent with those of in vitro studies with human ASM cells [35, 36]. Interestingly, asthma patients display lower expression of RGS2 in epithelial cells and ASM cells in lung and circulating monocytes . RGS5-deficient mice also showed spontaneous AHR, even without antigen sensitization in association with enhanced Ca2+ mobilization, ERK activation, and ASM cell contraction . In both cases, however, appreciable infiltration of inflammatory cells in the lung and production of cytokines, such as IL-4 and IL-5, was not observed [38, 39]. These results suggest that T-cell activation is not always required for GPCR-mediated asthma pathophysiology.
3.2. Mucus Hypersecretion in Epithelial Cells
Mucus hypersecretion is a common pathological feature of inflammatory airway diseases, including asthma. Liu et al.  have recently shown that an acidic pH of 6.4 stimulates mucin5AC (MUC5AC) secretion in the human bronchial epithelial cell line (16HBE) through the OGR1/Gq/phospholipase C pathway (Figure 2). Knockdown of OGR1 and Gq expression with small interfering RNAs inhibited acidification-induced increases in and mucin production. Similarly, overexpression of RGS2 protein attenuated acidic pH-induced cellular responses, whereas knockdown of RGS2 slightly but significantly enhanced these responses. These results suggest that airway acidification induces mucin production through the OGR1 and Gq, of which activation can be regulated by RGS2. The same group has also shown that TRPV1 is expressed and citric acid (pH 5.0)-induced mucin secretion is mediated by Ca2+ influx via TRPV1 in the same cells . These results suggest that epithelial cells utilize different proton-sensing machineries depending on the acidity of microenvironments; OGR1-family GPCRs sense mild alkaline to acidic pH of 8 to 6, whereas TRPV1 senses more acidic pH of 6 to 4, as described above.
3.3. Leukocyte Adhesion to and Leakage through Endothelial Cells
GPR4 has been shown to be expressed in endothelial cells and to be activated by extracellular acidification, leading to accumulation of cAMP, which may be relevant to normal blood vessel formation . Chen et al. have recently shown that activation of GPR4 by acidosis increases endothelial cell adhesion of monocytes in association with the expression of adhesion molecules, such as VCAM-1 and ICAM-1, through the cAMP/Epac pathway . Since VCAM-1 on the endothelium has been shown to mediate eosinophil adhesion and transmigration , this suggests that GPR4 is involved in the perivascular accumulation of eosinophils in the lung with inflammatory asthma (Figure 2). However, it remains unknown whether GPR4 deficiency affects eosinophilia in the airways with asthma.
3.4. Airway Eosinophilia due to Enhanced Survival of Eosinophils
Kottyan et al.  have reported that acidic pH increased eosinophil viability due to an inhibition of apoptosis, which was associated with an increase in cAMP accumulation. The acidic pH-induced increase in cell viability was attenuated by the adenylyl cyclase inhibitor and, in contrast, the phosphodiesterase inhibitor, the cell-permeable cAMP analog, and forskolin mimicked the acidic pH effect. The acidification-induced increase in eosinophil viability and cAMP accumulation was completely lost in the cells isolated from the TDAG8 knockout mice. These results suggest that eosinophil viability is increased in acidic microenvironments through the TDAG8/cAMP pathway (Figure 2). However, the mechanism by which cAMP inhibits eosinophil apoptosis remains unknown .
3.5. Cytokine and Production in Macrophages and Neutrophils
In macrophages, TDAG8 and OGR1 are expressed. Extracellular acidification inhibited lipopolysaccharide (LPS)-induced TNF-α and IL-6 protein and mRNA production in mouse peritoneal macrophages . The inhibitory action on cytokine production by acidic pH was significantly attenuated in macrophages from TDAG8-deficient mice but not in those from OGR1-deficient mice. Further characterization revealed that acidic pH inhibited proinflammatory cytokine production through the TDAG8/Gs/cAMP/PKA signaling pathway in mouse macrophages. The expression of TDAG8 was increased by glucocorticoid in the macrophage, which was associated with the enhancement of acidification-induced inhibition of TNF-α production . Thus, TDAG8 seems to be indirectly involved in glucocorticoid-induced anti-inflammatory actions.
Extracellular acidification has been shown to induce human neutrophil activation, inducing an increase in , a shape-changing response, upregulation of the expression of CD18, an inhibition of apoptosis, and enhancement of agonist-induced H2O2 production . These acidic pH-induced responses are accompanied by the activation of Akt and ERK. On the other hand, acidic pH has also been shown to inhibit some neutrophil functions. Extracellular acidic pH inhibits migration  and production in human neutrophils . Although intracellular acidification was supposed to, in part, explain the acidic pH-induced actions [48, 50], the precise proton-sensing mechanisms remained largely unknown. Murata et al.  have shown that acidic pH inhibited fMLP- and C5a-induced superoxide anion production. The acidic pH effect was mimicked by cAMP increasing agents and attenuated by a PKA inhibitor. Moreover, acidic pH increased cAMP accumulation. TDAG8 is coupled to cAMP signaling pathways and is abundantly expressed in neutrophils. These data suggest that TDAG8 may mediate extracellular acidification-induced inhibition of production through cAMP .
Thus, TDAG8 is coupled to anti-inflammatory cAMP signaling pathways in macrophages and neutrophils. Consistently with an anti-inflammatory role, TDAG8-deficient mice showed exacerbation of anti-type II collagen antibody-induced arthritis, in which macrophages and neutrophils have been shown to play a critical role . However, it remains uncharacterized whether the anti-inflammatory actions of TDAG8 in macrophages and neutrophils are involved in the pathophysiology of airway inflammation of asthma.
3.6. T-Cell Priming and Polarization by Dendritic Cells
Geffner and his colleagues have shown that extracellular acidification (pH 6.5) stimulates internalization of antigens; upregulated the expression of cell surface proteins, including CD11c, MHC class II, CD40, and CD86, involved in antigen presentation; and promoted an efficient MHC class I-restricted presentation of antigen peptides in dendritic cells (DCs) of C57BL/6 mice . Antigen-pulsed DCs under acidic pH showed an improved efficacy for inducing both specific CD8+ cytotoxic T lymphocytes and specific antibody responses in vivo . They further characterized acidic pH effects using human DCs and found that the transient exposure of human DCs to pH of 6.5 markedly increases several costimulatory proteins and improves the T-cell priming ability of DCs, which was associated with a dramatic increase in p38MAK-dependent IL-12 production. DC maturation by acidic pH stimulated the production of IFN-γ, but not of IL-4, by antigen-specific CD4+ T cells. These results suggest that extracellular acidification may contribute to the initiation of adaptive immune responses by DCs, favoring the development of the Th1 phenotype in humans .
Basu and Srivastava suggested that TRPV1 is expressed in mouse DCs and involved in their maturation . However, the role of TRPV1 is controversial. TRPV1 expression was not confirmed and either capsaicin or acidic pH failed to elicit a change in or the membrane current in mouse DCs . Recent studies have shown that TRPV1 is expressed in human DCs; however, in this case, the channel seems to inactivate rather than activate their maturation . The role of ASICs has also been suggested . ASIC1, ASIC2, and ASIC3 are expressed in mouse DCs, and selective inhibitors for ASICs, such as amiloride and nonsteroidal anti-inflammatory drugs (NSAIDs), inhibited acidic pH 6.5-induced expression of cell-surface molecules CD11c, MHC class II, CD80, and CD86.
We have recently examined the role of proton-sensing GPCRs in DC functions . Mouse DCs express OGR1-family receptors, including OGR1; the functional expression of OGR1 was confirmed by the extracellular acidic pH- and OGR1-dependent increase in . OVA-sensitized DCs from OGR1-deficient mice showed the reduction in the expression of CCR7, a chemokine receptor for mature DCs, and the migration responses to CCL19 and CCL21, ligands for CCR7, as compared with those from wild-type mice . Thus, OGR1 seems to be functioning in the migratory process of DCs to draining lymph nodes (see the next section).
4. Role of Proton-Sensing Channels and OGR1-Family GPCRs in Asthma Models
Although the contribution of TRPV1 to acidic pH-induced cough and bronchoconstriction is well demonstrated as discussed, it remains to be proven whether TRPV1-mediated neurogenic inflammation plays a central role in asthma and other respiratory diseases. The inarticulate conclusion is based on the lack of obvious effects by gene targeting experiments; TRPV1 deficiency did not attenuate or rather enhanced the airway inflammation and AHR as induced by LPS , antigens [61, 62], and cigarette smoke  in TRPV1 knockout mice. The anti-inflammatory role of TRPV1 might be, in part, explained by the release of anti-inflammatory somatostatin from the sensory nerve terminals in response to TRPV1 stimulation . Regardless, the role of TRPV1 in the airway inflammation and AHR remains to be established in mice. However, uncertain results with mice may be partly explained by the strain difference: the previous studies [60–63] used C57BL/6. Rehman et al.  have recently shown that TRPV1 knockdown with siRNA attenuates IL-13- and antigen-induced asthmatic features including airway inflammation and AHR in Balb/c mice.
In addition to proton-sensing channels, proton-sensing GPCRs also play an important role in the pathophysiology of asthma. As described above, Kottyan et al. have shown that TDAG8 deficiency causes the stimulation of eosinophil apoptosis and, thereby, reduces airway eosinophilia in OVA- and Aspergillus fumigatus-sensitization models of mice in vivo . They have also shown increased expression of TDAG8 in lungs from OVA-sensitized mice and in nasal brushing samples from pediatric asthma patients. Unfortunately, whether AHR and airway inflammation as cardinal features of asthma are modulated by TDAG8 in vivo has not been examined; however, it is noted that IL-13 production, which plays a role in these processes, was not affected by TDAG8 deficiency .
The findings of the expression of proton-sensing OGR1 in DC, a critical cell for antigen recognition and its presentation to T cells, and the involvement of OGR1 in the DC migration process  suggest participation of OGR1 in the pathophysiology of allergic asthma. Indeed, OGR1-deficient mice are resistant to the cardinal features of asthma, including airway eosinophilia, AHR, and goblet cell metaplasia, in association with a remarkable inhibition of the production of Th2 cytokines, including IL-4, IL-5, and IL-13, and OVA-specific IgE in an OVA-induced asthma model . Intratracheal transfer to wild-type mice of OVA-primed bone marrow-derived DCs from OGR1-deficient mice developed lower AHR and eosinophilia as compared with the transfer of those from wild-type mice, which was associated with lower migratory activity to the peribronchial lymph nodes in OGR1-deficient DCs than in wild-type DCs. These results suggest that stimulation of OGR1 on DCs is critical for the early processes, that is, migration to lymph nodes and initiation of Th2 polarization, and, thereby, induces eosinophilia, airway inflammation, and AHR . Since OGR1 is expressed in structural cells, including ASM cells and epithelial cells, and functions in a variety of cell-specific responses, the reduction of AHR and goblet hyperplasia in OGR1-deficient mice may be partly attributed to the reduction of acidification-induced constriction of ASM cells [35, 36] and mucin production in epithelial cells .
Finally, it should be noted that acidic pH modulates DCs leading to Th1 polarization in humans as described , which contrasts with the role of OGR1 in Th2 polarization in mice. The reason for the difference in the fate of T cells, that is, Th1 or Th2, is currently unknown. DCs express proton-sensing GPCRs other than OGR1, and OGR1-family GPCRs are expressed in neutrophils and macrophages as well. Therefore, differences in experimental conditions, for example, species, stimulants, antigens, and pH, may modify the state of DC activation and DC-T cell interaction, making naïve T cells polarize to Th1, Th2, Th17, or other phenotypes. How change in the pH microenvironment modulates DC function and T cell polarization warrants further study.
Proton-sensing channels, such as TRPV1 and ASICs, and OGR1-family GPCRs are expressed in structural cells, including ASM cells and epithelial cells, and inflammatory and immune cells, including eosinophils and DCs, and play a variety of roles in airway responses, depending on the optimum pH of proton-sensing channels and GPCRs. Cough and bronchoconstriction are activated by severe acidic pH of 4 to 5 and are mainly mediated by pH-sensing channels through sensory neurons, although pH-sensing OGR1 on ASM cells may also be involved in the cell constriction. At mild alkaline or mild acidic pH of more than 6, however, OGR1-family GPCRs may be the main receptors involved in the regulation of airway responses under pathophysiological situations, such as allergic asthma. Thus, ionotropic and metabotropic proton-sensing receptors may be therapeutic targets for inflammatory and ischemic diseases, such as asthma, for which drugs that are more specific and have fewer side effects are still required.
List of Abbreviations
|ASIC:||Acid-sensing ion channel|
|ASM:||Airway smooth muscle|
|ERK:||Extracellular signal-regulated kinase|
|GPCR:||G protein-coupled receptor|
|OGR1:||Ovarian cancer G protein-coupled receptor 1|
|RGS:||Regulator of G protein signaling|
|TDAG8:||T cell-death associated gene 8|
|TNF-α:||Tumor necrosis factor-α|
|TRPV1:||Transient receptor potential vanilloid-1|
|PKA:||Protein kinase A.|
Conflict of Interests
The authors declare that there is no conflict of interests regarding the publication of this paper.
- J. F. Hunt, K. Fang, R. Malik et al., “Endogenous airway acidification: implications for asthma pathophysiology,” American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 1, pp. 694–699, 2000.
- F. L. M. Ricciardolo, B. Gaston, and J. Hunt, “Acid stress in the pathology of asthma,” Journal of Allergy and Clinical Immunology, vol. 113, no. 4, pp. 610–619, 2004.
- M. Kodric, A. N. Shah, L. M. Fabbri, and M. Confalonieri, “An investigation of airway acidification in asthma using induced sputum: A study of feasibility and correlation,” The American Journal of Respiratory and Critical Care Medicine, vol. 175, no. 9, pp. 905–910, 2007.
- P. Holzer, “Acid-sensitive ion channels and receptors,” Handbook of Experimental Pharmacology, vol. 194, pp. 283–332, 2009.
- K. H. Banner, F. Igney, and C. Poll, “TRP channels: emerging targets for respiratory disease,” Pharmacology and Therapeutics, vol. 130, no. 3, pp. 371–384, 2011.
- L. Y. Lee, Q. Gu, F. Xu, and J. l. Hong, “Acid-sensing by airway afferent nerves,” Pulmonary Pharmacology & Therapeutics, vol. 26, no. 5, pp. 491–497, 2013.
- M. Tominaga and T. Tominaga, “Structure and function of TRPV1,” Pflugers Archiv, vol. 451, no. 1, pp. 143–150, 2005.
- Y. Jia and L. Lee, “Role of TRPV receptors in respiratory diseases,” Biochimica et Biophysica Acta, vol. 1772, no. 8, pp. 915–927, 2007.
- P. K. Smith and B. Nilius, “Transient receptor potentials (TRPs) and anaphylaxis,” Current Allergy and Asthma Reports, vol. 13, no. 1, pp. 93–100, 2013.
- M. S. Grace, M. Baxter, E. Dubuis, M. A. Birrell, and M. G. Belvisi, “Transient receptor potential (TRP) channels in the airway: role in airway disease,” British Journal of Pharmacology, vol. 171, no. 10, pp. 2593–2607, 2014.
- Z. G. Xiong, G. Pignataro, M. Li, S. Y. Chang, and R. P. Simon, “Acid-sensing ion channels (ASICs) as pharmacological targets for neurodegenerative diseases,” Current Opinion in Pharmacology, vol. 8, no. 1, pp. 25–32, 2008.
- E. Lingueglia, “Acid-sensing ion channels in sensory perception,” The Journal of Biological Chemistry, vol. 282, no. 24, pp. 17325–17329, 2007.
- J. Jasti, H. Furukawa, E. B. Gonzales, and E. Gouaux, “Structure of acid-sensing ion channel 1 at 1.9 Å resolution and low pH,” Nature, vol. 449, no. 7160, pp. 316–323, 2007.
- M. Paukert, X. Chen, G. Polleichtner, H. Schindelin, and S. Gründer, “Candidate amino acids involved in H+ gating of acid-sensing ion channel 1a,” The Journal of Biological Chemistry, vol. 283, no. 1, pp. 572–581, 2008.
- O. Bardou, N. T. N. Trinh, and E. Brochiero, “Molecular diversity and function of K+ channels in airway and alveolar epithelial cells,” The American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 296, no. 2, pp. L145–L155, 2009.
- M. I. Hollenhorst, K. Richter, and M. Fronius, “Ion transport by pulmonary epithelia,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 174306, 16 pages, 2011.
- G. Burnstock, I. Brouns, D. Adriaensen, and J. Timmermans, “Purinergic signaling in the airways,” Pharmacological Reviews, vol. 64, no. 4, pp. 834–868, 2012.
- M. Ludwig, M. Vanek, D. Guerini et al., “Proton-sensing G-protein-coupled receptors,” Nature, vol. 425, no. 6953, pp. 93–98, 2003.
- H. Tomura, C. Mogi, K. Sato, and F. Okajima, “Proton-sensing and lysolipid-sensitive G-protein-coupled receptors: a novel type of multi-functional receptors,” Cellular Signalling, vol. 17, no. 12, pp. 1466–1476, 2005.
- K. Seuwen, M. Ludwig, and R. M. Wolf, “Receptors for protons or lipid messengers or both?” Journal of Receptors and Signal Transduction, vol. 26, no. 5-6, pp. 599–610, 2006.
- F. Okajima, “Regulation of inflammation by extracellular acidification and proton-sensing GPCRs,” Cellular Signalling, vol. 25, no. 11, pp. 2263–2271, 2013.
- J. Wang, J. Kon, C. Mogi et al., “TDAG8 is a proton-sensing and psychosine-sensitive G-protein-coupled receptor,” Journal of Biological Chemistry, vol. 279, no. 44, pp. 45626–45633, 2004.
- S. Ishii, Y. Kihara, and T. Shimizu, “Identification of T cell death-associated gene 8 (TDAG8) as a novel acid sensing g-protein-coupled receptor,” Journal of Biological Chemistry, vol. 280, no. 10, pp. 9083–9087, 2005.
- M. Tobo, H. Tomura, C. Mogi et al., “Previously postulated “ligand-independent” signaling of GPR4 is mediated through proton-sensing mechanisms,” Cellular Signalling, vol. 19, no. 8, pp. 1745–1753, 2007.
- J. P. Liu, T. Nakakura, H. Tomura et al., “Each one of certain histidine residues in G-protein-coupled receptor GPR4 is critical for extracellular proton-induced stimulation of multiple G-protein-signaling pathways,” Pharmacological Research, vol. 61, no. 6, pp. 499–505, 2010.
- J. H. Kabarowski, “G2A and LPC: regulatory functions in immunity,” Prostaglandins & Other Lipid Mediators, vol. 89, no. 3-4, pp. 73–81, 2009.
- C. G. Radu, A. Nijagal, J. McLaughlin, L. Wang, and O. N. Witte, “Differential proton sensitivity of related G protein-coupled receptors T cell death-associated gene 8 and G2A expressed in immune cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 5, pp. 1632–1637, 2005.
- C. Faisy, B. Planquette, E. Naline et al., “Acid-induced modulation of airway basal tone and contractility: role of acid-sensing ion channels (ASICs) and TRPV1 receptor,” Life Sciences, vol. 81, no. 13, pp. 1094–1102, 2007.
- L. Lee and Q. Gu, “Role of TRPV1 in inflammation-induced airway hypersensitivity,” Current Opinion in Pharmacology, vol. 9, no. 3, pp. 243–249, 2009.
- M. Kollarik, F. Ru, and B. J. Undem, “Acid-sensitive vagal sensory pathways and cough,” Pulmonary Pharmacology & Therapeutics, vol. 20, no. 4, pp. 402–411, 2007.
- J. Szolcsányi, “Forty years in capsaicin research for sensory pharmacology and physiology,” Neuropeptides, vol. 38, no. 6, pp. 377–384, 2004.
- H. Satoh, Y.-P. Lou, and J. M. Lundberg, “Inhibitory effects of capsazepine and SR 48968 on citric acid-induced bronchoconstriction in guinea-pigs,” European Journal of Pharmacology, vol. 236, no. 3, pp. 367–372, 1993.
- I. Delescluse, H. Mace, and J. J. Adcock, “Inhibition of airway hyperresponsiveness by TRPV1 antagonists (SB-705498 and PF-04065463) in the unanaesthetized, ovalbumin-sensitizedguinea pig,” British Journal of Pharmacology, vol. 166, no. 6, pp. 1822–1832, 2012.
- S. C. Grifoni, S. E. McKey, and H. A. Drummond, “Hsc70 regulates cell surface ASIC2 expression and vascular smooth muscle cell migration,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 294, no. 5, pp. H2022–H2030, 2008.
- I. Ichimonji, H. Tomura, C. Mogi et al., “Extracellular acidification stimulates IL-6 production and Ca2+ mobilization through proton-sensing OGR1 receptors in human airway smooth muscle cells,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 299, no. 4, pp. L567–L577, 2010.
- H. Saxena, D. A. Deshpande, B. C. Tiegs et al., “The GPCR OGR1 (GPR68) mediates diverse signalling and contraction of airway smooth muscle in response to small reductions in extracellular pH,” British Journal of Pharmacology, vol. 166, no. 3, pp. 981–990, 2012.
- S. Matsuzaki, T. Ishizuka, H. Yamada et al., “Extracellular acidification induces connective tissue growth factor production through proton-sensing receptor OGR1 in human airway smooth muscle cells,” Biochemical and Biophysical Research Communications, vol. 413, no. 4, pp. 499–503, 2011.
- Y. Xie, H. Jiang, H. Nguyen et al., “Regulator of G protein signaling 2 is a key modulator of airway hyperresponsiveness,” Journal of Allergy and Clinical Immunology, vol. 130, no. 4, pp. 968–976, 2012.
- N. A. Balenga, W. Jester, M. Jiang, R. A. Panettieri Jr., and K. M. Druey, “Loss of regulator of G protein signaling 5 promotes airway hyperresponsiveness in the absence of allergic inflammation,” Journal of Allergy and Clinical Immunology, vol. 134, no. 2, pp. 451.e11–459.e11, 2014.
- C. Liu, Q. Li, X. Zhou, V. P. Kolosov, and J. M. Perelman, “Regulator of G-protein signaling 2 inhibits acid-induced mucin5AC hypersecretion in human airway epithelial cells,” Respiratory Physiology & Neurobiology, vol. 185, no. 2, pp. 265–271, 2013.
- H. Yu, Q. Li, X. Zhou, V. P. Kolosov, and J. M. Perelman, “Transient receptor potential vanilloid 1 receptors mediate acid-induced mucin secretion via Ca2+ influx in human airway epithelial cells,” Journal of Biochemical and Molecular Toxicology, vol. 26, no. 5, pp. 179–186, 2012.
- L. V. Yang, C. G. Radu, M. Roy et al., “Vascular abnormalities in mice deficient for the G protein-coupled receptor GPR4 that functions as a pH sensor,” Molecular and Cellular Biology, vol. 27, no. 4, pp. 1334–1347, 2007.
- A. Chen, L. Dong, N. R. Leffler, A. S. Asch, O. N. Witte, and L. V. Yang, “Activation of GPR4 by acidosis increases endothelial cell adhesion through the cAMP/Epac pathway,” PLoS ONE, vol. 6, no. 11, Article ID e27586, 2011.
- M. W. Johansson and D. F. Mosher, “Integrin activation States and eosinophil recruitment in asthma,” Frontiers in Pharmacology, vol. 4, article 33, 2013.
- L. C. Kottyan, A. R. Collier, K. H. Cao et al., “Eosinophil viability is increased by acidic pH in a cAMP- and GPR65-dependent manner,” Blood, vol. 114, no. 13, pp. 2774–2782, 2009.
- C. Mogi, M. Tobo, H. Tomura et al., “Involvement of proton-sensing TDAG8 in extracellular acidification-induced inhibition of proinflammatory cytokine production in peritoneal macrophages,” The Journal of Immunology, vol. 182, no. 5, pp. 3243–3251, 2009.
- X. He, M. Tobo, C. Mogi et al., “Involvement of proton-sensing receptor TDAG8 in the anti-inflammatory actions of dexamethasone in peritoneal macrophages,” Biochemical and Biophysical Research Communications, vol. 415, no. 4, pp. 627–631, 2011.
- A. S. Trevani, G. Andonegui, M. Giordano et al., “Extracellular acidification induces human neutrophil activation,” The Journal of Immunology, vol. 162, no. 8, pp. 4849–4857, 1999.
- O. D. Rotstein, V. D. Fiegel, R. L. Simmons, and D. R. Knighton, “The deleterious effect of reduced pH and hypoxia on neutrophil migration in vitro,” Journal of Surgical Research, vol. 45, no. 3, pp. 298–303, 1988.
- L. Simchowitz, “Intracellular pH modulates the generation of superoxide radicals by human neutrophils,” Journal of Clinical Investigation, vol. 76, no. 3, pp. 1079–1089, 1985.
- N. Murata, C. Mogi, M. Tobo et al., “Inhibition of superoxide anion production by extracellular acidification in neutrophils,” Cellular Immunology, vol. 259, no. 1, pp. 21–26, 2009.
- Y. Onozawa, T. Komai, and T. Oda, “Activation of T cell death-associated gene 8 attenuates inflammation by negatively regulating the function of inflammatory cells,” European Journal of Pharmacology, vol. 654, no. 3, pp. 315–319, 2011.
- M. Vermeulen, M. Giordano, A. S. Trevani et al., “Acidosis improves uptake of antigens and MHC class I-restricted presentation by dendritic cells,” Journal of Immunology, vol. 172, no. 5, pp. 3196–3204, 2004.
- D. Martínez, M. V. Vermeulen, E. Von Euw et al., “Extracellular acidosis triggers the maturation of human dendritic cells and the production of IL-12,” The Journal of Immunology, vol. 179, no. 3, pp. 1950–1959, 2007.
- S. Basu and P. Srivastava, “Immunological role of neuronal receptor vanilloid receptor 1 expressed on dendritic cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 14, pp. 5120–5125, 2005.
- P. J. O'Connell, S. C. Pingle, and G. P. Ahern, “Dendritic cells do not transduce inflammatory stimuli via the capsaicin receptor TRPV1,” FEBS Letters, vol. 579, no. 23, pp. 5135–5139, 2005.
- B. I. Tóth, S. Benko, A. G. Szöllosi, L. Kovács, É. Rajnavölgyi, and T. Bíró, “Transient receptor potential vanilloid-1 signaling inhibits differentiation and activation of human dendritic cells,” FEBS Letters, vol. 583, no. 10, pp. 1619–1624, 2009.
- J. Tong, W. N. Wu, X. Kong et al., “Acid-sensing ion channels contribute to the effect of acidosis on the function of dendritic cells,” The Journal of Immunology, vol. 186, no. 6, pp. 3686–3692, 2011.
- H. Aoki, C. Mogi, T. Hisada et al., “Proton-sensing ovarian cancer G protein-coupled receptor 1 on dendritic cells is required for airway responses in a murine asthma model,” PLoS ONE, vol. 8, no. 11, Article ID e79985, 2013.
- Z. Helyes, K. Elekes, J. Németh et al., “Role of transient receptor potential vanilloid 1 receptors in endotoxin-induced airway inflammation in the mouse,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 292, no. 5, pp. L1173–L1181, 2007.
- A. I. Caceres, M. Brackmann, M. D. Elia et al., “A sensory neuronal ion channel essential for airway inflammation and hyperreactivity in asthma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 22, pp. 9099–9104, 2009.
- T. Mori, K. Saito, Y. Ohki, H. Arakawa, M. Tominaga, and K. Tokuyama, “Lack of transient receptor potential vanilloid-1 enhances Th2-biased immune response of the airways in mice receiving intranasal, but not intraperitoneal, sensitization,” International Archives of Allergy and Immunology, vol. 156, no. 3, pp. 305–312, 2011.
- E. Andrè, B. Campi, S. Materazzi et al., “Cigarette smoke-induced neurogenic inflammation is mediated by α,β-unsaturated aldehydes and the TRPA1 receptor in rodents,” Journal of Clinical Investigation, vol. 118, no. 7, pp. 2574–2582, 2008.
- R. Rehman, Y. A. Bhat, L. Panda, and U. Mabalirajan, “TRPV1 inhibition attenuates IL-13 mediated asthma features in mice by reducing airway epithelial injury,” International Immunopharmacology, vol. 15, no. 3, pp. 597–605, 2013.
Copyright © 2014 Haruka Aoki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.